-
Masitinib May Slow ALS Progression
According to preclinical data, AB Science’s investigational therapy masitinib can modulate different cell types known to be implicated in ALS progression. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.